- Page 3/7
They recently completed their IPO. It struggle a bit out of the gate and has treaded water ever since. It is a fashion brand that has been out for long time. He does not see the growth here. There are a lot of better places to be in retail. Where is the expansion going to come from. He does not see the brand translating well into the US.
At these levels it is a great company for the long term. He owned it at one time. There is still room here. You end up kicking yourself for always thinking they are bit expensive. With housing coming back in the US, they are going to put some money back into their house. He would establish a half position and then see how it goes.
At these levels it is a great company for the long term. He owned it at one time. There is still room here. You end up kicking yourself for always thinking they are bit expensive. With housing coming back in the US, they are going to put some money back into their house. He would establish a half position and then see how it goes.
It is a great company. He just does not see how they can grow into their valuation and make money for shareholders. He would have said the same thing last year. Yet their subscriber numbers continue to grow. It is not growth at a reasonable price. AAPL-Q is at 15 times earnings and 12 if you take the cash off the balance sheet. AAPL-Q is still his number one holding in his portfolios.
It is a great company. He just does not see how they can grow into their valuation and make money for shareholders. He would have said the same thing last year. Yet their subscriber numbers continue to grow. It is not growth at a reasonable price. AAPL-Q is at 15 times earnings and 12 if you take the cash off the balance sheet. AAPL-Q is still his number one holding in his portfolios.
He bought it at this level 3 or 4 year ago. The growth has stopped. The HEP C drugs caused it to run as well but they cured people so it was not going to lend itself to a lot of recurring revenue. The worst is behind them. They have other drugs in HIV and Oncology that could get the growth back up.
He bought it at this level 3 or 4 year ago. The growth has stopped. The HEP C drugs caused it to run as well but they cured people so it was not going to lend itself to a lot of recurring revenue. The worst is behind them. They have other drugs in HIV and Oncology that could get the growth back up.
He would buy it at this price. He has owned it all year. They have continued to grow. They have expanded production again this year even if not at the same pace. They will be flat on Natural gas for the next year because there is not a lot of demand for more. They will change from a pure growth company to one that will pay a dividend – about 1.5%. This is still a good bet for the long run.
He would buy it at this price. He has owned it all year. They have continued to grow. They have expanded production again this year even if not at the same pace. They will be flat on Natural gas for the next year because there is not a lot of demand for more. They will change from a pure growth company to one that will pay a dividend – about 1.5%. This is still a good bet for the long run.
He wishes he was as positive on the long term prospects as with TOU-T. They sold some assets but he would stay on the sidelines with CVE-T.
He wishes he was as positive on the long term prospects as with TOU-T. They sold some assets but he would stay on the sidelines with CVE-T.
SU-T vs. CNQ-T. SU-T is a great company. With CNQ-T they are the two big guys in the field. He owns neither one but he would lean a little more to CNQ-T because of better valuation. The yield is not as great but they have more potential to bump the dividend up. Unit we get a better energy environment in Canada the growth will be limited.
SU-T vs. CNQ-T. SU-T is a great company. With CNQ-T they are the two big guys in the field. He owns neither one but he would lean a little more to CNQ-T because of better valuation. The yield is not as great but they have more potential to bump the dividend up. Unit we get a better energy environment in Canada the growth will be limited.
They recently completed their IPO. It struggle a bit out of the gate and has treaded water ever since. It is a fashion brand that has been out for long time. He does not see the growth here. There are a lot of better places to be in retail. Where is the expansion going to come from. He does not see the brand translating well into the US.